UBS Group’s G Medical Innovations Holdings Ltd. Warrants GMVDW Stock Holding History

UBS Group’s Portfolio GMVDW Stock Details GMVDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,919	Closed	-$1K	–	11453
2022 Q3	$1K	Sell	13,919 -3,800	-21%	-$306	﹤0.01%	10163
2022 Q2	$2K	Buy	+17,719	New	+$3.62K	﹤0.01%	9702
2022 Q1	–	Sell	-8,598	Closed	-$3K	–	11236
2021 Q4	$3K	Sell	8,598 -6,031	-41%	-$2.36K	﹤0.01%	9730
2021 Q3	$6K	Buy	+14,629	New	+$9.82K	﹤0.01%	8476

Other funds holding GMVDW

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

UBS Group's GMVDW Position: Q4 2022 in Review

UBS Group sold out of G Medical Innovations Holdings Ltd. Warrants (GMVDW) in Q4 2022, closing a stake of 13,919 shares — an estimated $1K sold.

UBS Group first reported a position in GMVDW in Q3 2021 and held it in 4 quarters. The position peaked at $6K in Q3 2021. 1 fund tracked by Wall St. Rank holds GMVDW as of Q4 2022.

UBS Group reported no remaining G Medical Innovations Holdings Ltd. Warrants position as of Q4 2022 after selling out during the quarter.
UBS Group sold 13,919 G Medical Innovations Holdings Ltd. Warrants shares in Q4 2022, an estimated $1K.
UBS Group first reported a position in G Medical Innovations Holdings Ltd. Warrants in Q3 2021 and held it in 4 quarters.
UBS Group's G Medical Innovations Holdings Ltd. Warrants position peaked at $6K in Q3 2021.
1 fund tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Warrants as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.